Israel - hebraico - Ministry of Health

pfizer pharmaceuticals israel ltd - tigecycline - אבקה מיובשת בהקפאה לאינפוזיה - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosu

Israel - hebraico - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tigecycline - אבקה להכנת תמיסה לאינפוזיה - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosu

Israel - hebraico - Ministry of Health

medison pharma ltd - daptomycin 500 mg/vial - lyophilized powder for injection - daptomycin - cubicin (daptomycin for injection) is indicated for the treatment of complicated skin and skin structure infections caused by susceptible strains of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant strains) streptococcus pyogenes streptococcus agalactiae streptococcus dysgalactiae subsp. equisimilis and enterococcus faecalis (vancomycin-susceptible strains only). combination therapy may be clinically indicated if the documented or presumed pathogens include gram-negative or anaerobic organisms. daptomycin is not indicated for the treatment of pneumonia. appropriate specimens for microbiological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to daptomycin. empiric therapy may be initiated while awaiting test results. antimicrobial therapy should be adjusted as needed based upon test results. to reduce the development of drug-resistant bacteria and maintain the effectiveness of cubici

Israel - hebraico - Ministry of Health

teva israel ltd - mycophenolate mofetil - טבליה - mycophenolate mofetil 500 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, in patients receiving allogenic cardiac transplants and in allogenic hepatic transplants. mycophenolate teva should be used concomitantly with ciclosporin and corticosteroids.

Israel - hebraico - Ministry of Health

pfizer pharmaceuticals israel ltd - ceftiofur hydrochloride 50 mg / 1 ml - suspension for injection - infections associated with bacteria sensitive to ceftiofur: in pigs : for the treatment of bacterial respiratory disease associated with pasteurella multocida actinobacillus pleuropneumoniae adn streptococcus suis. in cattle : for the treatment of bacterial respiratory disease associated with mannheimia spp. (pasteurella haemolytica) pasteurella multocida and haemophilus somnus. for the treatment of acute interdigital necrobacillosis ( panaritium foot rot) associated with fusobacterium necrophorum adn bacteroides melaninogenicus (porphyromonas asaccharolytica). for treatment of the bacterial coponent of acute post-partum (puerperal) metritis within 10 days after calving associated with escherichia coli arcanobacterium pyogenes and fusobacteriu necrophorum sensitive to ceftiofur.

Israel - hebraico - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - ניקוי הפנים

Israel - hebraico - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - ניקוי הפנים

Israel - hebraico - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - ניקוי הפנים

Israel - hebraico - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - ניקוי הפנים

Israel - hebraico - Ministry of Health

פישר מעבדות פרמצבטיות בעמ - מיצוק העור / מניעת צלוליט